CELLGENTEK CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,495 KRW | +0.20% |
|
-2.35% | -13.67% |
| 2023 | CELLGENTEK Co., Ltd. announced that it has received KRW 1.27795162 billion in funding | CI |
| 2023 | CELLGENTEK Co., Ltd. announced that it expects to receive KRW 1.27795162 billion in funding | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
More news
| 1 day | +0.20% | ||
| 1 week | -2.35% | ||
| Current month | -2.35% | ||
| 1 month | +8.48% | ||
| 3 months | +1.01% | ||
| 6 months | -19.26% | ||
| Current year | -13.67% |
1 week
2 300.00
2 900.00
1 month
2 105.002 990.00
Current year
1 955.006 220.00
1 year
1 955.006 220.00
3 years
1 955.0013 550.00
5 years
1 955.0023 050.00
10 years
1 955.0023 050.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hoi-Yul Kim
CEO | Chief Executive Officer | 48 | - |
Woo-Jung Son
BRD | Director/Board Member | 63 | - |
Eun-Ho Lee
AUD | Comptroller/Controller/Auditor | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Suk-Gil Song
BRD | Director/Board Member | 59 | - |
Hoi-Yul Kim
CEO | Chief Executive Officer | 48 | - |
Sook-Ryong Ma
BRD | Director/Board Member | 58 | - |
CELLGENTEK Co., Ltd, formerly PCPIA BIT Co.,Ltd., is a Korea-based company mainly engaged in the development and sale of software. The Company is involved in the manufacturing and sale of analysis systems, simulators, software and solutions. The main products consist of solutions for batch control of bio equipments, e-mail management solutions, solutions for management of the reagent records and safety protection under the name of Lab Bio Plus, as well as solutions for pharmaceutical management.
Sector
Software
| 1st Jan change | Capi. | |
|---|---|---|
| -13.67% | 7.2M | |
| +11.33% | 324B | |
| +26.30% | 218B | |
| +1.57% | 147B | |
| +14.56% | 58.1B | |
| +2.45% | 31.33B | |
| +7.00% | 30.66B | |
| +95.06% | 22.3B | |
| +28.72% | 21.09B | |
| +2.09% | 14.88B |
- Stock Market
- Equities
- A258250 Stock